SKAN Group AG, together with its subsidiaries, provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally. It operates in two segments, Equipment and Solutions; and Services and Consumables. The company offers accessories, biological indicators, digital ventures, isolators, cleanroom, laminar flow, particle counter, personal protective equipment, safety workbench, transfer systems, and fume cupboard. It also provides digital solutions, lifecycle support, laboratory services, and SKAN labs. The company was formerly known as BV Holding AG and changed its name to SKAN Group AG in October 2021. SKAN Group AG was founded in 1968 and is headquartered in Allschwil, Switzerland.…
Leiter des Bereichs Services, Digital und Single-Use-Systeme der Skan Group von Vorwürfen des Insiderhandels freigesprochen; CFO legt Berufung gegen erstinstanzliche Verurteilung ein
SKAN Group (SWX: SKAN) is listed on the SIX Swiss Exchange, where its shares trade in CHF. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 1,694 employees.
The shares were at 67.40 CHF on 20 November 2026, up 46.2% over 52 weeks. Its 52-week range is 35.75 CHF to 77.40 CHF: the price is 12.9% below the high and 88.5% above the low.
At a market capitalisation of 1.52B CHF, it trades at 50.7 times trailing earnings and 36.6 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 48.3, so SKAN is valued in line with them. It pays a dividend yielding 0.32% (it pays out 17% of its earnings), against a median of 0.92% among the dividend payers in that peer group.
SKAN Group reports return on equity of 14.2%, an operating margin of 10.7% and revenue up 22.2% year over year.
Its debt exceeds its cash by 42.16M CHF, a debt-to-equity ratio of 1.15. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 2 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 72.00 CHF is 6.8% above the current price. The next earnings report is expected on 23 March 2027.